Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

MCRB Seres Therapeutics Inc

0,8281

-0,0029 (-0,35%)

03 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Seres Therapeutics Charts.

Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Seres Therapeutics Charts.

News Seres Therapeutics Inc

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
Montag 16 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Montag 9 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
Freitag 22 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 29 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 29 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Seres Therapeutics Inc News-Artikel

Gold vs US Dollar

Invesco QQQ Trust Series 1

Deutsche Lufthansa

Euro vs US Dollar

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen